MRI-Guided Thrombolysis in Stroke of Unknown Onset

MRI-Guided Thrombolysis in Stroke of Unknown Onset


MRI-Guided Thrombolysis in Stroke of Unknown Onset

null


Content

8.179 -> Intravenous thrombolysis is not recommended in acute ischemic stroke
11.966 -> if the time of onset is not known
14.16 -> or if the stroke occurred more than 4.5 hours earlier.
17.7 -> However, in some unwitnessed acute ischemic strokes,
20.12 -> including those with symptoms on awakening,
22.34 -> patients are unaware of the time of symptom onset.
25.32 -> MRI that shows an ischemic lesion on diffusion weighted images (or DWI)
30.34 -> but no marked parenchymal hyperintensity on fluid-attenuated inversion recovery
35.08 -> (or FLAIR) images in the same region, a DWI-FLAIR mismatch,
39.48 -> can be predictive of symptom onset within the previous 4.5 hours.
43.8 -> The role of intravenous thrombolysis in patients
45.82 -> with acute stroke of unknown time of symptom onset
48.72 -> and DWI-FLAIR mismatch is unclear.
52.51 -> In this multicenter, randomized, double-blind, placebo-controlled trial, 503 patients diagnosed
57.6 -> with stroke with an unknown time of symptom onset
60.32 -> and a DWI-FLAIR mismatch received intravenous alteplase or placebo.
65.4 -> The primary outcome was a favorable clinical outcome, defined as a score of 0, no symptoms,
70.84 -> or 1, no significant disability despite residual symptoms,
74.72 -> on the modified Rankin scale at 90 days after the stroke.
78.58 -> The primary outcome occurred in 53.3% of the alteplase group and 41.8% of the placebo group.
85.74 -> There were 10 deaths with alteplase and 3 with placebo,
89 -> a difference that was not statistically significant.
91.9 -> Clinically significant extracranial bleeding
93.94 -> was observed in 3 patients in the alteplase group,
96.3 -> but was not observed in the placebo group.
98.64 -> There was no difference in the rate of intracerebral hemorrhage.
101.84 -> The authors conclude that intravenous thrombolysis with alteplase improved functional outcomes
106.509 -> in stroke patients with unknown time of symptom onset and MRI findings of a DWI-FLAIR mismatch.
113.95 -> Full trial results are available at NEJM.org

Source: https://www.youtube.com/watch?v=jmOZIQI7Yhs